Andrea Gilg

448 total citations
9 papers, 211 citations indexed

About

Andrea Gilg is a scholar working on Immunology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Andrea Gilg has authored 9 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 3 papers in Infectious Diseases and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Andrea Gilg's work include Immunotherapy and Immune Responses (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Andrea Gilg is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Andrea Gilg collaborates with scholars based in Germany, India and Egypt. Andrea Gilg's co-authors include Jan Münch, Janis A. Müller, Carina Conzelmann, Frank Kirchhoff, Benjamin Mayer, Rüdiger Groß, Ludger Ständker, Bernd Jahrsdörfer, Hubert Schrezenmeier and Mirja Harms and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Andrea Gilg

9 papers receiving 211 citations

Peers

Andrea Gilg
Steve Anderson United States
Ashley Otter United Kingdom
Glenda Canderan United States
Michael D. Schultz United States
Lindsey Placek United States
Andrea Gilg
Citations per year, relative to Andrea Gilg Andrea Gilg (= 1×) peers Joshua G. Liang

Countries citing papers authored by Andrea Gilg

Since Specialization
Citations

This map shows the geographic impact of Andrea Gilg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Gilg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Gilg more than expected).

Fields of papers citing papers by Andrea Gilg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Gilg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Gilg. The network helps show where Andrea Gilg may publish in the future.

Co-authorship network of co-authors of Andrea Gilg

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Gilg. A scholar is included among the top collaborators of Andrea Gilg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Gilg. Andrea Gilg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Harms, Mirja, Andrea Gilg, Jessica Löffler, et al.. (2023). Development of N-Terminally Modified Variants of the CXCR4-Antagonistic Peptide EPI-X4 for Enhanced Plasma Stability. Journal of Medicinal Chemistry. 66(22). 15189–15204. 6 indexed citations
2.
Rodríguez, Armando, Andrea Gilg, Ludger Ständker, et al.. (2022). Advanced EPI-X4 Derivatives Covalently Bind Human Serum Albumin Resulting in Prolonged Plasma Stability. International Journal of Molecular Sciences. 23(23). 15029–15029. 8 indexed citations
3.
Sokkar, Pandian, Mirja Harms, Christina M. Stürzel, et al.. (2021). Computational modeling and experimental validation of the EPI-X4/CXCR4 complex allows rational design of small peptide antagonists. Communications Biology. 4(1). 1113–1113. 20 indexed citations
4.
Groß, Rüdiger, Alina Seidel, Carina Conzelmann, et al.. (2021). Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants. EBioMedicine. 75. 103761–103761. 95 indexed citations
5.
Gilg, Andrea, et al.. (2021). Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations. Journal of Translational Medicine. 19(1). 190–190. 2 indexed citations
6.
Conzelmann, Carina, Tatjana Weil, Andrea Gilg, et al.. (2021). Virucidal activity of SARS-CoV-2 rapid antigen extraction buffers. Journal of Clinical Virology. 147. 105062–105062. 3 indexed citations
7.
Harms, Mirja, Andrea Gilg, Ludger Ständker, et al.. (2020). Microtiter plate-based antibody-competition assay to determine binding affinities and plasma/blood stability of CXCR4 ligands. Scientific Reports. 10(1). 16 indexed citations
8.
Harms, Mirja, Andrea Gilg, Nico Preising, et al.. (2020). An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation. Acta Pharmaceutica Sinica B. 11(9). 2694–2708. 32 indexed citations
9.
Conzelmann, Carina, Andrea Gilg, Rüdiger Groß, et al.. (2020). An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection. Antiviral Research. 181. 104882–104882. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026